Cue Health Inc. (HLTH) Tops Q1 EPS by 13c; offers guidance

Cue Health Inc. (NASDAQ: HLTH) reported Q1 EPS of ($0.48), $0.13 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $62.59 million.

GUIDANCE:

Cue Health Inc. sees Q2 2023 revenue of $8-10 million reflecting an expected shift to a seasonal respiratory pattern for COVID testing volumes, versus the consensus of $20.976 million.

For earnings history and earnings-related data on Cue Health Inc. (HLTH) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c